CVE-2024-27177

Remote Code Execution

Description

An attacker can get Remote Code Execution by overwriting files. Overwriting files is enable by falsifying package name variable. This vulnerability can be executed in combination with other vulnerabilities and difficult to execute alone. So, the CVSS score for this vulnerability alone is lower than the score listed in the "Base Score" of this vulnerability. For detail on related other vulnerabilities, please ask to the below contact point. https://www.toshibatec.com/contacts/products/ As for the affected products/models/versions, see the reference URL.

Remediation

Solution:

  • This issue is fixed in the version released on June 14, 2024 and all later versions.

Category

7.2
CVSS
Severity: High
CVSS 3.1 •
EPSS 1.82% Top 20%
Affected: Toshiba Tec Corporation Toshiba Tec e-Studio multi-function peripheral (MFP)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-27177?
CVE-2024-27177 has been scored as a high severity vulnerability.
How to fix CVE-2024-27177?
To fix CVE-2024-27177: This issue is fixed in the version released on June 14, 2024 and all later versions.
Is CVE-2024-27177 being actively exploited in the wild?
It is possible that CVE-2024-27177 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27177?
CVE-2024-27177 affects Toshiba Tec Corporation Toshiba Tec e-Studio multi-function peripheral (MFP).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.